Translational Cancer Research

eISSN: 2219-6803pISSN: 2218-676X

Journal formatting to fit the target journal guidelines

Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!

Key Metrics

CiteScore
0.8
Impact Factor
< 5
SJR
Q4Oncology
SNIP
0.16

Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
  • Publisher
    AME PUBLISHING COMPANY
  • Language
    English
  • Frequency
    Monthly
General Details
View less

Ready to spotlight your research findings?

Impress peers and journals alike with a concise, visual summary of your work.

Meets Top Publisher Standards: Essential for leading journals like Elsevier.
Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.
Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
Learn more 3000+ graphical abstracts produced with 4.8/5 customer rating

Topics Covered

Cancer
Cell growth
Overall survival
Lung cancer
Lymph node
Bioinformatics analysis
Portal vein
Chemoradiotherapy
Small intestine
Immunotherapy
Breast cancer
Hepatocellular carcinoma
Crizotinib
Epidermal growth factor receptor
Key genes
Extracellular vesicles
Nasopharyngeal carcinoma
Head and neck
Hepatitis B
Carcinogenesis

Recently Published Papers

Year-wise Publication

FAQs

Since when has Translational Cancer Research been publishing? Faqs

The Translational Cancer Research has been publishing since 2012 till date.

How frequently is the Translational Cancer Research published? Faqs

Translational Cancer Research is published Monthly.

Who is the publisher of Translational Cancer Research? Faqs

The publisher of Translational Cancer Research is AME PUBLISHING COMPANY.

How can I view the journal metrics of Translational Cancer Research on editage? Faqs

For the Translational Cancer Research metrics, please refer to the section above on the page.

What is the eISSN and pISSN number of Translational Cancer Research? Faqs

The eISSN number is 2219-6803 and pISSN number is 2218-676X for Translational Cancer Research.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding Cancer, Cell growth, Overall survival, Lung cancer, Lymph node, Bioinformatics analysis, Portal vein, Chemoradiotherapy, Small intestine, Immunotherapy, Breast cancer, Hepatocellular carcinoma, Crizotinib, Epidermal growth factor receptor, Key genes, Extracellular vesicles, Nasopharyngeal carcinoma, Head and neck, Hepatitis B, Carcinogenesis.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.